Liver cancer risk check for people with hepatitis B
Part of Cancer clinical trials.
This study looks at your risk of developing liver cancer if you have hepatitis B. It uses your medical history and test results to give you a better idea of your risk and help guide next steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have hepatitis B (positive for hepatitis B surface antigen).
- You should also have at least one of: cirrhosis, type 2 diabetes, a family history of cirrhosis or liver cancer, long-term heavy alcohol use, a liver biopsy showing scarring, or a high liver stiffness measurement (FibroScan).
- You cannot have any current cancer, have had a liver transplant, or have HIV.
- You must be expected to live more than a year and have no severe organ problems or mental health conditions that would make participation difficult.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to predict the risk of developing liver cancer in people with chronic liver conditions such as hepatitis B or C, cirrhosis, or fatty liver disease. By participating, you may help researchers improve early detection and prevention strategies for liver cancer.
This study is testing a new way to predict if people with chronic hepatitis B, who also have liver fibrosis or cirrhosis, might develop liver cancer (HCC). It uses your medical data to create a risk score, which could help you and your doctor plan earlier and more tailored monitoring.
This study checks if a simple score (FIB-4) can help find early liver cancer in people with type 2 diabetes. It aims to see if regular monitoring could help catch cancer sooner.
This study tests a new way to find liver cancer early in people who are at higher risk, using regular ultrasound and blood tests. If you qualify, you'll get close monitoring to catch any problems sooner, which may improve treatment options.
This study is looking at how well antiviral treatments work to prevent liver cancer in people with chronic hepatitis B who have a family history of the disease. If you are over 30 and taking antiviral medication, you may be able to join.
This study looks at your risk of developing liver cancer (hepatocellular carcinoma) if you have a liver condition such as NAFLD or a related disease. It aims to improve how doctors predict who might be at higher risk, so they can offer better monitoring and care.
Hear when a new HBV-related Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.